Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection: Clinical article

Journal of Neurosurgery

Volumn 114, Issue 3, 2011, Pages 604-612

  Chaichana, Kaisorn L ^a   Halthore, Aditya N ^a   Parker, Scott L ^a   Olivi, Alessandro ^a   Weingart, Jon D ^a   Brem, Henry ^a   Quinones Hinojosa, Alfredo ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Functional outcome; Glioblastoma; Karnofsky performance scale; Quality of life; Recurrence; Temozolomide

Indexed keywords

CARMUSTINE; CISPLATIN; LOMUSTINE; METHOTREXATE; PROCARBAZINE; TEMOZOLOMIDE; VINCRISTINE;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; FUNCTIONAL STATUS; GLIOBLASTOMA; HEADACHE; HUMAN; KARNOFSKY PERFORMANCE STATUS; LANGUAGE DISABILITY; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; NAUSEA AND VOMITING; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; PRIMARY TUMOR; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; SECOND CANCER; SEIZURE; SENSORY DYSFUNCTION; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR VOLUME; VISUAL FIELD DEFECT;

AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; COMBINED MODALITY THERAPY; DACARBAZINE; DRUG IMPLANTS; FEMALE; GLIOBLASTOMA; HUMANS; INDEPENDENT LIVING; KAPLAN-MEIER ESTIMATE; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OBSERVER VARIATION; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SUPRATENTORIAL NEOPLASMS; SURVIVAL; TREATMENT OUTCOME;

EID: 77958012289     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2010.4.JNS091340     Document Type: Article

References (46)

1. al-Sarraj S, Bridges LR: p53 immunoreactivity in astrocytomas and its relationship to survival. Br J Neurosurg 9:143-149, 1995
2. Altman DG: Practical Statistics for Medical Research. New York: Chapman & Hall/CRC, 1991
3. Barker FG II, Prados MD, Chang SM, Gutin PH, Lamborn KR, Larson DA, et al: Radiation response and survival time in patients with glioblastoma multiforme. J Neurosurg 84:442-448, 1996 (Pubitemid 26062869)
4. Boarini DJ, Beck DW, VanGilder JC: Postoperative prophylactic anticonvulsant therapy in cerebral gliomas. Neurosurgery 16:290-292, 1985 (Pubitemid 15109991)
5. Brown PD, Ballman KV, Rummans TA, Maurer MJ, Sloan JA, Boeve BF, et al: Prospective study of quality of life in adults with newly diagnosed high-grade gliomas. J Neurooncol 76:283-291, 2006
6. Brown PD, Maurer MJ, Rummans TA, Pollock BE, Ballman KV, Sloan JA, et al: A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery 57:495-504, 2005
7. Buckner JC: Factors influencing survival in high-grade gliomas. Semin Oncol 30 (6 Suppl 19):10-14, 2003
8. Bussière M, Hopman W, Day A, Pombo AP, Neves T, Espinosa F: Indicators of functional status for primary malignant brain tumour patients. Can J Neurol Sci 32:50-56, 2005 (Pubitemid 40363577)
9. Carson KA, Grossman SA, Fisher JD, Shaw EG: Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials. J Clin Oncol 25:2601-2606, 2007 (Pubitemid 47041234)
10. Carter AN, Cole CL, Playle AG, Ramsay EJ, Shervington AA: GPR26: a marker for primary glioblastoma? Mol Cell Probes 22:133-137, 2008 (Pubitemid 351337632)
11. Chang EF, Potts MB, Keles GE, Lamborn KR, Chang SM, Barbaro NM, et al: Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg 108:227-235, 2008 (Pubitemid 351213284)
12. Chang SM, Parney IF, Huang W, Anderson FA Jr, Asher AL, Bernstein M, et al: Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293:557-564, 2005 (Pubitemid 40171237)
13. Chang SM, Parney IF, McDermott M, Barker FG II, Schmidt MH, Huang W, et al: Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg 98:1175-1181, 2003 (Pubitemid 36617917)
14. Claes A, Idema AJ, Wesseling P: Diffuse glioma growth: a guerilla war. Acta Neuropathol 114:443-458, 2007 (Pubitemid 47521501)
15. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, et al: Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:704-710, 1993 (Pubitemid 23133591)
16. De Haan R, Horn J, Limburg M, Van Der Meulen J, Bossuyt P: A comparison of five stroke scales with measures of disability, handicap, and quality of life. Stroke 24:1178-1181, 1993 (Pubitemid 23237556)
17. DeAngelis LM: Brain tumors. N Engl J Med 344:114-123, 2001
18. Dropcho EJ, Soong SJ: The prognostic impact of prior low grade histology in patients with anaplastic gliomas: a case-control study. Neurology 47:684-690, 1996 (Pubitemid 26307298)
19. Hildebrand J, Lecaille C, Perennes J, Delattre JY: Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology 65:212-215, 2005 (Pubitemid 41022363)
20. Hollen PJ, Gralla RJ, Kris MG, Cox C, Belani CP, Grunberg SM, et al: Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale. Cancer 73:2087-2098, 1994 (Pubitemid 24107963)
21. Keles GE, Chang EF, Lamborn KR, Tihan T, Chang CJ, Chang SM, et al: Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma. J Neurosurg 105:34-40, 2006 (Pubitemid 43979095)
22. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, et al: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-229, 2002
23. Kleihues P, Ohgaki H: Primary and secondary glioblastomas: from concept to clinical diagnosis. Neuro Oncol 1:44-51, 1999
24. Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, et al: Long-term survival with glioblastoma multiforme. Brain 130:2596-2606, 2007 (Pubitemid 47511715)
25. Lamborn KR, Chang SM, Prados MD: Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol 6:227-235, 2004 (Pubitemid 39136506)
26. Law J, Fielding B, Jackson D, Turner-Stokes L: The UK FIM+FAM Extended Activities of Daily Living module: evaluation of scoring accuracy and reliability. Disabil Rehabil 31:825-830, 2009
27. Laws ER Jr, Taylor WF, Clifton MB, Okazaki H: Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. J Neurosurg 61:665-673, 1984 (Pubitemid 14009855)
28. Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, et al: Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 99:467-473, 2003 (Pubitemid 37040405)
29. Lopez S, Taillibert S, Idbaih A, Simon JM, Mazeron JJ: [Should elderly patients with glioblastoma be proposed to radiotherapy?] Cancer Radiother 12:827-830, 2008 (Fr)
30. Maschio M, Albani F, Baruzzi A, Zarabla A, Dinapoli L, Pace A, et al: Levetiracetam therapy in patients with brain tumour and epilepsy. J Neurooncol 80:97-100, 2006 (Pubitemid 44473268)
31. McGirt MJ, Chaichana KL, Gathinji M, Attenello FJ, Than K, Olivi A, et al: Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg 110:156-162, 2009
32. McGirt MJ, Mukherjee D, Chaichana KL, Than KD, Weingart JD, Quinones-Hinojosa A: Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery 65:463-470, 2009
33. McKee G: Are there meaningful longitudinal changes in health related quality of life-SF36, in cardiac rehabilitation patients? Eur J Cardiovasc Nurs 8:40-47, 2008
34. Miller PJ, Hassanein RS, Giri PG, Kimler BF, O'Boynick P, Evans RG: Univariate and multivariate statistical analysis of high-grade gliomas: the relationship of radiation dose and other prognostic factors. Int J Radiat Oncol Biol Phys 19:275-280, 1990 (Pubitemid 20299018)
35. North CA, North RB, Epstein JA, Piantadosi S, Wharam MD: Low-grade cerebral astrocytomas. Survival and quality of life after radiation therapy. Cancer 66:6-14, 1990 (Pubitemid 20197076)
36. Perry JR, Sawka C: Add-on gabapentin for refractory seizures in patients with brain tumours. Can J Neurol Sci 23:128-131, 1996 (Pubitemid 26186481)
37. Recht L, Glantz M, Chamberlain M, Hsieh CC: Quantitative measurement of quality outcome in malignant glioma patients using an independent living score (ILS). Assessment of a retrospective cohort. J Neurooncol 61:127-136, 2003 (Pubitemid 36253658)
38. Schag CC, Heinrich RL, Ganz PA: Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol 2:187-193, 1984 (Pubitemid 14138407)
39. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005 (Pubitemid 40349501)
40. Tait MJ, Petrik V, Loosemore A, Bell BA, Papadopoulos MC: Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases. Br J Neurosurg 21:496-500, 2007
41. Taphoorn MJ, Stupp R, Coens C, Osoba D, Kortmann R, van den Bent MJ, et al: Health-related quality of life in patients with glioblastoma: a randomised controlled trial. Lancet Oncol 6:937-944, 2005 (Pubitemid 41685226)
42. Taylor BV, Buckner JC, Cascino TL, O'Fallon JR, Schaefer PL, Dinapoli RP, et al: Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma. J Clin Oncol 16:2195-2201, 1998 (Pubitemid 28265058)
43. van Veelen ML, Avezaat CJ, Kros JM, van Putten W, Vecht C: Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery. J Neurol Neurosurg Psychiatry 64:581-587, 1998 (Pubitemid 28204142)
44. Wagner GL, Wilms EB, Van Donselaar CA, Vecht ChJ: Levetiracetam: preliminary experience in patients with primary brain tumours. Seizure 12:585-586, 2003 (Pubitemid 37509054)
45. Watanabe K, Tachibana O, Sata K, Yonekawa Y, Kleihues P, Ohgaki H: Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 6:217-224, 1996 (Pubitemid 26246377)
46. Wick W, Menn O, Meisner C, Steinbach J, Hermisson M, Tatagiba M, et al: Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long? Onkologie 28:391-396, 2005 (Pubitemid 41558255)